Wi-Fi Securities Limited is a cyber security company that aims to revolutionise the security of public access Wi-Fi. To realise this vision, the company is developing a unique patent-protected system called SpriteGuard™ which will protect you and your data from hackers by stopping you connecting to fake hotspots. The system is targeted towards the $550 bn worldwide hospitality industry and has the ability to expand to other large global markets like city-wide free Wi-Fi, airports and coffee shops. Moreover, Wi-Fi Securities Limited has a highly experienced Wi-Fi Securities management board that has a track record of delivering multi-million-pound projects from concept to successful commercial deployment.
days to go:
Extended
investment:
£1,014,708
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Morgan Goodwin is a UK-based company that pioneers the Combined Trading Platform (CTP) category, offering a comprehensive online platform for small businesses engaged in physical goods trading, along with specialized software development services, and a broad-spectrum business consultancy approach aimed at enhancing growth, efficiency, and technological advancement.
days to go:
Stretch
investment:
£788,519
Doqit offers a solution for managing life admin tasks, helping you organize important information, set action dates, and receive timely reminders, ultimately streamlining tasks like insurance renewals and warranties to reduce unnecessary expenses and simplify your life. It provides secure storage and easy access for vital information, transitioning from chaos to simplicity.
Security is also a priority for Doqit. The platform ensures that your sensitive information is stored securely, giving you peace of mind knowing that you can access your important documents and data whenever you need them, all within a few clicks.
days to go:
Extended
investment:
£87,500
UTU is a company dedicated to building the trust infrastructure for the evolving web 3.0. They aim to facilitate safer and more reliable interactions between users and platforms by utilizing a decentralized reputation and reviews protocol. This protocol involves a non-tradable reputation token (UTT) that users can stake to endorse others, leading to positive outcomes. UTU's focus initially lies in Web3 and DeFi apps, where they provide AI-powered tools to curate trust signals and help users engage confidently in various online activities. They offer a range of products, including the UTU Trust Token, Browser Extension, and Trust API/SDK, all aimed at enhancing trust and security in digital interactions.
days to go:
Extended
investment:
£150,000
NGX is the world’s first genetically personalised nutrition shake designed to bring nutrition to everyday athletes. The company has ongoing discussions to form partners with U.A.E and U.S to expand. NGX's nutritionist approved formula is a less than average vegan-friendly, environmentally responsible, allergen-free, naturally sourced, and macro trends within the millennial and Z generations. With the proceeds, the company aims to create a range of products from personalised meal plans, and protein bars to enhance its position as the go-to personalised nutrition brand.
days to go:
Expired
investment:
£207,860
Balkerne is designing a commercial insurance product based on Risk Management technology and Property & Casualty Insurance. Through this way, the company helps enterprises defend their property and people. The company will make sure that no property owner suffers from theft, fire or flood. It has generated net revenue of £21K in January 2019. The revenue model of Balkerne is to charge a percentage of the premium to distribute insurance and support customers with risk management by managing claims. The company has come up with an exit strategy that is to improve the performance of the acquiring company and to quickly acquire the skills and technologies at a lower cost.
days to go:
Expired
investment:
£150,000
KegTracker is a company that has launched an innovative Internet of Things (IoT) enabled device that turns kegs into smart containers. The device tracks real-time location, volume, temperature and motion for each keg in order to create reports & insights that enable a sustainable supply chain. The company asserts that a lack of transparency in managing kegs has led to annual industry losses of £1.4 billion+ in theft and spoilage, £1 billion+ in poor distribution, and £500 million+ in suboptimal production and lost containers. KegTracker argues that its device can reduce these losses significantly. The company has developed a working prototype, filed a patent and received letters of interest from leading UK breweries, coffee roasters and Wales National Health Service (NHS). In 2019, the company featured in Startups Magazine and were finalists at FutureFood Awards, London & Partners BGP, and Pitch@Palace. It will use the investment to bring its product to more markets.
days to go:
Expired
investment:
£511,428
